LTQ XL Linear Ion Trap Mass Spectrometer
LTQ XL 线性离子阱质谱仪
基本信息
- 批准号:7595676
- 负责人:
- 金额:$ 38.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-04 至 2010-02-03
- 项目状态:已结题
- 来源:
- 关键词:ArtsAspartateCataractComplex MixturesCore FacilityDetectionDiabetes MellitusDiseaseDissociationDrug InteractionsElectron TransportFundingHealth SciencesHemochromatosisIonsMalignant NeoplasmsMethamphetamineModificationNeurodegenerative DisordersOregonPhosphorylationPlayPost-Translational Protein ProcessingPreparationProteinsProteomicsProteomics Shared ResourceResearchResearch PersonnelRoleSamplingScanningSerumSourceSpeedSubcellular FractionsTissuesUniversitiesaddictionglycosylationhearing impairmenthuman diseaseimprovedinstrumentmass spectrometerpublic health relevancetool
项目摘要
DESCRIPTION (provided by applicant): We request a ThermoFisher LTQ XL linear ion trap with an electron transfer dissociation source to be placed in the Oregon Health & Science University's Proteomics Shared Resource (PSR). Due to the high sensitivity and fast scan rates, this instrument will be used to identify proteins in complex mixtures of precipitated proteins in Protein/Protein or Protein/Drug interaction studies, preparations of subcellular fractions, extracts of microdissected tissues, and immuno-depleted serum samples. The electron transfer dissociation source will be used to improve the detection and localization of post-translational modifications, including phosphorylation, glycosylation and isomerization of aspartate. The instrument will play a crucial role in 12 diverse projects studying the causes of human disease including cataracts, hearing loss, neurodegenerative disease in the young and old, cancer, methamphetamine addiction, hemochromatosis, and diabetes. The introduction of this instrument will fulfill the growing needs of the researchers at the Oregon Health & Sciences University to incorporate state-of-the-art tools in proteomics into their research. This will speed their progress of discovery to improve the detection and treatment of human disease. PUBLIC HEALTH RELEVANCE: We request funding for an LTQ XL ion trap mass spectrometer to identify proteins and detect their modifications. This instrument will be placed in a shared core facility and will help investigate the cause and treatment of diseases ranging from cancer to hearing loss at the Oregon Health & Science University.
描述(由申请人提供):我们请求将带有电子转移解离源的ThermoFisher LTQ XL线性离子陷阱放置在俄勒冈健康与科学大学的蛋白质组学共享资源(PSR)中。由于高灵敏度和快速扫描速度,该仪器将用于鉴定蛋白质/蛋白质或蛋白质/药物相互作用研究中沉淀蛋白质的复杂混合物中的蛋白质,亚细胞组分的制备,显微解剖组织的提取物,以及免疫耗竭的血清样本。电子转移解离源将用于改进翻译后修饰的检测和定位,包括天冬氨酸的磷酸化、糖基化和异构化。该仪器将在12个不同的项目中发挥关键作用,这些项目研究人类疾病的原因,包括白内障、听力损失、年轻人和老年人的神经退行性疾病、癌症、甲基苯丙胺成瘾、血色素沉着症和糖尿病。这种仪器的推出将满足俄勒冈健康与科学大学研究人员将最先进的蛋白质组学工具纳入他们的研究的日益增长的需求。这将加快他们的发现进度,以改进人类疾病的检测和治疗。与公共健康相关:我们要求为LTQ XL离子陷阱质谱仪提供资金,以识别蛋白质并检测其修饰。该仪器将被放置在一个共享的核心设施中,并将在俄勒冈健康与科学大学帮助调查从癌症到听力损失的各种疾病的原因和治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARRY L DAVID其他文献
LARRY L DAVID的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARRY L DAVID', 18)}}的其他基金
Role of crystallin racemization and isomerization in cataract
晶状体蛋白外消旋和异构化在白内障中的作用
- 批准号:
9752550 - 财政年份:2017
- 资助金额:
$ 38.87万 - 项目类别:
Role of crystallin racemization and isomerization in cataract
晶状体蛋白外消旋和异构化在白内障中的作用
- 批准号:
9933672 - 财政年份:2017
- 资助金额:
$ 38.87万 - 项目类别:
Role of crystallin racemization and isomerization in cataract
晶状体蛋白外消旋和异构化在白内障中的作用
- 批准号:
10011819 - 财政年份:2017
- 资助金额:
$ 38.87万 - 项目类别:
Role of crystallin racemization and isomerization in cataract
晶状体蛋白外消旋和异构化在白内障中的作用
- 批准号:
10242798 - 财政年份:2017
- 资助金额:
$ 38.87万 - 项目类别:
LINEAR ION TRAP MASS SPECTROMETER: CELL BIOLOGY
线性离子阱质谱仪:细胞生物学
- 批准号:
7166314 - 财政年份:2005
- 资助金额:
$ 38.87万 - 项目类别:
LINEAR ION TRAP MASS SPECTROMETER: EYE, VISION
线性离子阱质谱仪:眼睛、视觉
- 批准号:
7166311 - 财政年份:2005
- 资助金额:
$ 38.87万 - 项目类别:
相似国自然基金
固本祛湿化瘀方调控银屑病角质细胞与初始T细胞Aspartate交互的机制研究
- 批准号:82305246
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Balancing redox homeostasis and the metabolic network through metabolite compartmentalisation: SLC25A13, aspartate, and the mitochondrion
通过代谢物区室平衡氧化还原稳态和代谢网络:SLC25A13、天冬氨酸和线粒体
- 批准号:
BB/Y002865/1 - 财政年份:2023
- 资助金额:
$ 38.87万 - 项目类别:
Research Grant
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 38.87万 - 项目类别:
Regulation of brown fat fuel utilization by the malate-aspartate shuttle
苹果酸-天冬氨酸穿梭对棕色脂肪燃料利用的调节
- 批准号:
10712090 - 财政年份:2023
- 资助金额:
$ 38.87万 - 项目类别:
The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells
苹果酸-天冬氨酸穿梭将膳食脂肪酸与树突状细胞的炎症反应联系起来
- 批准号:
10772912 - 财政年份:2023
- 资助金额:
$ 38.87万 - 项目类别:
The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells
苹果酸-天冬氨酸穿梭将膳食脂肪酸与树突状细胞的炎症反应联系起来
- 批准号:
10528235 - 财政年份:2022
- 资助金额:
$ 38.87万 - 项目类别:
L-Aspartate signalling in the brain
大脑中的 L-天冬氨酸信号传导
- 批准号:
MR/W028964/1 - 财政年份:2022
- 资助金额:
$ 38.87万 - 项目类别:
Research Grant
Manipulating N-acetyl-L-aspartate transport to treat Canavan leukodystrophy
操纵 N-乙酰基-L-天冬氨酸转运来治疗 Canavan 脑白质营养不良
- 批准号:
10406711 - 财政年份:2022
- 资助金额:
$ 38.87万 - 项目类别:
Manipulating N-acetyl-L-aspartate transport to treat Canavan leukodystrophy
操纵 N-乙酰基-L-天冬氨酸转运来治疗 Canavan 脑白质营养不良
- 批准号:
10554428 - 财政年份:2022
- 资助金额:
$ 38.87万 - 项目类别:
Role of altered endoplasmic reticulum calcium regulation and the N-methyl-D-aspartate (NMDA) receptor signaling in cortico-striatal synaptic dysfunction: Opportunities for therapy in prodromal Huntington disease
改变的内质网钙调节和 N-甲基-D-天冬氨酸 (NMDA) 受体信号在皮质纹状体突触功能障碍中的作用:前驱期亨廷顿病的治疗机会
- 批准号:
443591 - 财政年份:2021
- 资助金额:
$ 38.87万 - 项目类别:
Operating Grants
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
一项 2b 期、双盲、随机对照试验,旨在评估 Inebilizumab 在抗 N-甲基-D-天冬氨酸受体 (NMDAR) 脑炎中的活性和安全性并评估疾病标志物
- 批准号:
10185824 - 财政年份:2021
- 资助金额:
$ 38.87万 - 项目类别:














{{item.name}}会员




